How should we use anti-CTLA-4 antibodies?

被引：7
|
作者：
Marabelle, Aurelien [1 ,2 ]
Eggermont, Alexander [1 ]
机构：
[1] Gustave Roussy Canc Campus Grand Paris, F-94805 Villejuif, France
[2] INSERM, U1015, F-94805 Villejuif, France
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷 / 17期
关键词：
REGULATORY T-CELLS; METASTATIC MELANOMA; IPILIMUMAB;
D O I：
10.1016/j.ejca.2015.09.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2686 / 2688
页数：3
相关论文
共 50 条
  • [41] Investigation of the effects on distant metastases treated by direct lymph node administration of anti-CTLA-4 antibodies
    Takagi, Koki
    Miyatsu, Miriu
    Radhika, Mishra
    Ariunbuyan, Sukhbaatar
    Mori, Shiro
    Kodama, Tetsuya
    CANCER SCIENCE, 2023, 114 : 1183 - 1183
  • [42] Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
    Babamohamadi, Mehregan
    Mohammadi, Nastaran
    Faryadi, Elham
    Haddadi, Maryam
    Merati, Amirhossein
    Ghobadinezhad, Farbod
    Amirian, Roshanak
    Izadi, Zhila
    Hadjati, Jamshid
    CELL DEATH & DISEASE, 2024, 15 (01) : 17
  • [43] Anti-CTLA-4 Therapy Expands T Cell Range
    不详
    SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (254)
  • [44] Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
    Salvatori, Erika
    Lione, Lucia
    Compagnone, Mirco
    Pinto, Eleonora
    Conforti, Antonella
    Ciliberto, Gennaro
    Aurisicchio, Luigi
    Palombo, Fabio
    NPJ VACCINES, 2022, 7 (01)
  • [45] Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
    Erika Salvatori
    Lucia Lione
    Mirco Compagnone
    Eleonora Pinto
    Antonella Conforti
    Gennaro Ciliberto
    Luigi Aurisicchio
    Fabio Palombo
    npj Vaccines, 7
  • [46] Anti-CTLA-4 therapy requires an Fc domain for efficacy
    Ingram, Jessica R.
    Blomberg, Olga S.
    Rashidian, Mohammad
    Ali, Lestat
    Garforth, Scott
    Fedorov, Elena
    Fedorov, Alexander A.
    Bonanno, Jeffrey B.
    Le Gall, Camille
    Crowley, Stephanie
    Espinosa, Camilo
    Biary, Tamara
    Keliher, Edmund J.
    Weissleder, Ralph
    Almo, Steven C.
    Dougan, Stephanie K.
    Ploegh, Hidde L.
    Dougan, Michael
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (15) : 3912 - 3917
  • [47] Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
    Mehregan Babamohamadi
    Nastaran Mohammadi
    Elham Faryadi
    Maryam Haddadi
    Amirhossein Merati
    Farbod Ghobadinezhad
    Roshanak Amirian
    Zhila Izadi
    Jamshid Hadjati
    Cell Death & Disease, 15
  • [48] Systematic review: colitis associated with anti-CTLA-4 therapy
    Gupta, A.
    De Felice, K. M.
    Loftus, E. V., Jr.
    Khanna, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (04) : 406 - 417
  • [49] Recent Advances Using Anti-CTLA-4 for the Treatment of Melanoma
    Sarnaik, Amod A.
    Weber, Jeffrey S.
    CANCER JOURNAL, 2009, 15 (03): : 169 - 173
  • [50] Anti-CTLA-4 induced pathological changes of the gastrointestinal tract
    Oble, Darryl Alan
    Seliem, Rania M.
    Hasserjian, Robert
    Lauwers, Gregory Y.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S278 - S278
12345